MLH1 and neoplasm: To address this question we performed NGS MSI panel analysis and MSI‐PCR with a monomorphic marker assay in 263 tumor samples with known IHC dMMR status (n = 103 samples with a loss in MSH2/MSH6 or MLH1/PMS2 protein expression).